Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
VOLITIONRX LTD
Insider Ann-Louise Batchelor of VolitionRX Ltd reported a change in beneficial ownership of company securities on October 21, 2026. This filing serves as a Form 4 statement regarding the insider's stock holdings.…more
VOLITIONRX LTD
VolitionRx Ltd insider Gael Forterre filed a Form 4 statement of changes in beneficial ownership of securities on September 28, 2026. This filing serves as an official record of the insider's equity transaction.…more
VOLITIONRX LTD
Insider Michel Gaetan of VolitionRx Ltd filed a Form 4 report on September 30, 2026, regarding changes in beneficial ownership of securities as of September 28, 2026.…more
17 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
VolitionRx Launches DETECSEPS Sepsis Detection Project With $7.3M French Funding…more
VolitionRx has officially launched the DETECSEPS project, a sepsis early detection initiative backed by approximately $7.3 million in French government funding. The company will provide its Nu.Q NETs assay as the exclusive biomarker for this collaborative research effort.…more
●●●●●●●● ●●●●● ●●●●●●
VolitionRx has fully repaid its $7.5 million convertible promissory note held by Lind Global Asset Management in cash. While all obligations related to this specific note have been satisfied, other outstanding debt obligations remain.…more
●●●●●●●● ●●●●● ●●●●●●
VolitionRx has filed a prospectus with the SEC for the sale of 10 million common shares by existing shareholders. This offering involves secondary shares rather than new issuance, though it may still impact market liquidity and share price.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.